Abstract
The CHADS2 score is useful in stratifying the risk of ischemic stroke or transient ischemic attack (TIA) in patients with non-valvular atrial fibrillation (AF). However, it remains unclear whether the CHADS2 score could predict stroke or TIA in chronic heart failure (CHF) patients without AF. Recently, the new stroke risk score was proposed from 2 contemporary heart failure trials. We evaluated the prognostic power of the CHADS2 score for stroke or TIA in CHF patients without AF in comparison to the “stroke risk score”. We retrospectively studied 127 CHF patients [left ventricular ejection fraction (LVEF) <40 %] without AF, who had been enrolled in our previous prospective cohort study. The primary endpoint was the incidence of stroke or TIA. The mean baseline CHADS2 score was 2.1 ± 1.0. During the follow-up period of 8.4 ± 5.1 years, stroke or TIA occurred in 21 of 127 patients. At multivariate Cox analysis, CHADS2 score (C-index 0.794), but not “stroke risk score” (C-index 0.625), was significantly and independently associated with stroke or TIA. The incidence of stroke or TIA appeared to increase in relation to the CHADS2 score [low (=1), 0 per 100 person-years; intermediate (=2), 1.6 per 100 person-years; high (≥3), 4.7 per 100 person-years; p = 0.04]. CHADS2 score could stratify the risk of ischemic stroke in CHF patients with the absence of AF, with greater prognostic power than the “stroke risk score”.
Similar content being viewed by others
References
Caldwell JC, Mamas MA, Neyses L, Garratt CJ (2010) What are the thromboembolic risks of heart failure combined with chronic or paroxysmal AF? J Card Fail 16:340–347
Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I (2009) Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J 50:591–600
Chong A, Blann A, Patel J, Freestone B, Hughes E, Lip GY (2004) Endothelial dysfunction and damage in congestive heart failure. Circulation 110:1794–1798
Lip GY, Gibbs CR (1999) Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 33:1424–1426
Haeusler K, Laufs U, Endres M (2011) Chronic heart failure and ischemic stroke. Stroke 42:2977–2982
Sadanaga T, Kohsaka S, Mitamura H, Ogawa S (2011) Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation. Heart Vessels 26:530–535
Witt BJ, Brown RD, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Michi K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119:e391–e479
Suzuki S, Yamashita T, Okumura K, Atarashi T, Akao M, Ogawa H, Inoue H (2015) Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy. Circ J 79:432–438
Kishima H, Mine T, Kodani T, Masuyama T (2015) Prediction of left atrial thrombi in patients with atrial tachyarrhythmias during warfarin administration: retrospective study in Hyogo College of Medicine. Heart Vessels 30:331–337
Welles CMD, Whooley M, Na B, Ganz P, Schiller NB, Turakhia MP (2011) The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among patients with coronary heart disease: data from the heart and soul study. Am Heart J 162:555–561
Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray;, JJInvestigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA), GISSI-Heart Failure (GISSI-HF) Committees and Investigators (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza cardiaca-heart failure (GISSI-HF) trials. Circulation 131:1486–1494
McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446
Goris ML, McKillop JH, Brijandet PA (1981) A fully automated determination of the left ventricular region of interest in nuclear angiography. Cardiovasc Intervent Radiol 4:117–123
Sahn DJ, Demaria A, Kissio J, Weyman A (1978) Recommendation regarding quantification in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation 58:1072–1083
Foti A, Kimura S, DeQuattro V, Lee D (1987) Liquid-chromatographic measurement of catecholamines and metabolites in plasma and urine. Clin Chem 33:2209–2213
Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M (1995) Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization monitoring trends and determinants in cardiovascular disease. Stroke 26:361–367
Beer MH, Porter RS, Jones TV (2006) The merck manual, eighteenth edn. Merck & Co Inc, Kenilworth, pp 1423–1425
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458
Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG (1997) Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 80:1566–1571
McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, Kappas A (2005) Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c. Diabetologia 48:345–350
Hamatani Y, Iguchi M, Nakamura M, Ohtani R, Yamashita Y, Takagi D, Unoki T, Ishii M, Masunaga N, Ogawa H, Hamatani M, Abe M, Akao M (2015) Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure. Heart Vessels. doi:10.1007/s00380-015-0719-4
Belen E, Ozal E, Pusuroglu H (2015) Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm. Heart Vessels. doi:10.1007/s00380-015-0759-9
Liu Y, Wang K, Su D, Cong T, Cheng Y, Zhang Y, Wu J, Sun Y, Shang Z, Liu J, Zhong L, Zou L, Chitian C, Zhang X, Jiang Y (2014) Noninvasive assessment of left atrial phasic function in patients with hypertension and diabetes using two-dimensional speckle tracking and volumetric parameters. Echocardiography 31:727–735
Kochi K, Kanehiro K, Mukada K, Hasada J, Kajihara S, Orihashi K, Sueda T, Matsuura Y (1999) Relationship between left atrial spontaneous echo contrast and the features of middle cerebral artery territory in nonvalvular atrial fibrillation. Heart Vessels 14:149–153
Katoh S, Honda S, Watanabe T, Suzuki S, Ishino M, Kitahara T, Funayama A, Netsu S, Sasaki T, Shishido T, Miyamoto T, Sadahiro M, Kubota I (2014) Atrial endothelial impairment through Toll-like receptor 4 signaling causes atrial thrombogenesis. Heart Vessels 29:263–272
Homma S, Thompson J, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R, Investigators WARCEF (2012) Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 366:1859–1869
Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA (2004) The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148:157–164
Lip GY, Ponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, Morais J, Pullicino P, Rasmussen LH, Marin F, Lane DA, Task Force ESC (2012) Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. Eur J Heart Fail 14:681–695
Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347:969–974
Samol A, Masin M, Gellner R, Otte B, Pavenstädt HJ, Ringelstein EB, Reinecke H, Waltenberger J, Kirchhof P (2013) Prevalence of unknown atrial fibrillation in patients with risk factors. Europace 15:657–662
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial conflicts of interest to disclose concerning the paper.
Rights and permissions
About this article
Cite this article
Kondo, T., Yamada, T., Morita, T. et al. The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores. Heart Vessels 32, 193–200 (2017). https://doi.org/10.1007/s00380-016-0861-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-016-0861-7